Shinichi Uchida
Shizuoka, 4110943, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
High-dose carbidopa achieves sustained levodopa pharmacokinetics and efficacy in Parkinson's disease models.
Journal: The Journal of pharmacy and pharmacology
Published: August 26, 2025
The adenosine A2A receptor antagonist/inverse agonist, KW-6356 enhances the anti-parkinsonian activity of L-DOPA with a low risk of dyskinesia in MPTP-treated common marmosets.
Journal: Journal of pharmacological sciences
Published: March 05, 2023
Anti-parkinsonian activity of the adenosine A2A receptor antagonist/inverse agonist KW-6356 as monotherapy in MPTP-treated common marmosets.
Journal: European journal of pharmacology
Published: March 02, 2023
In Vitro Pharmacological Profile of KW-6356, a Novel Adenosine A2A Receptor Antagonist/Inverse Agonist.
Journal: Molecular pharmacology
Published: September 27, 2022
The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease.
Journal: Molecules (Basel, Switzerland)
Published: February 16, 2022
Identification of a Novel Peptide from β-Casein That Enhances Spatial and Object Recognition Memory in Mice.
Journal: Journal of agricultural and food chemistry
Published: June 27, 2019
Anxiolytic effects of theaflavins via dopaminergic activation in the frontal cortex.
Journal: Bioscience, biotechnology, and biochemistry
Published: February 27, 2019
Novel lactopeptides in fermented dairy products improve memory function and cognitive decline.
Journal: Neurobiology of aging
Published: March 16, 2018
Accumulation of autofluorescent storage material in brain is accelerated by ischemia in chloride channel 3 gene-deficient mice.
Journal: Journal of neuroscience research
Published: March 05, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026